ABMD DMA
As of date:8/13/2020
ABMD stock price:308.37
ABMD 50 DMA:272.44
ABMD 200 DMA:201.51
ABMD MACD (200-50):-70.93

Also see:
ABMD Market Cap History
ABMD Shares Outstanding History
ABMD YTD Return
ABMD RSI
ABMD MACD
ABMD Technical Analysis

CPAA Crosses Below Key Moving Average Level
41 minutes ago


iQIYI (IQ) Shares Cross Below 200 DMA
1 hour, 17 minutes ago


Kulicke & Soffa Industries Breaks Below 200-Day Moving Average - Notable for KLIC
1 hour, 30 minutes ago


Vericel Breaks Below 200-Day Moving Average - Notable for VCEL
1 hour, 30 minutes ago


Notable Two Hundred Day Moving Average Cross - IGHG
1 hour, 48 minutes ago


PURE Storage Breaks Below 200-Day Moving Average - Notable for PSTG
3 hours, 16 minutes ago


BioDelivery Sciences International (BDSI) Shares Cross Above 200 DMA
3 hours, 16 minutes ago


Garrett Motion (GTX) Shares Cross Above 200 DMA
3 hours, 17 minutes ago


GameStop (GME) Shares Cross Above 200 DMA
3 hours, 19 minutes ago


Transcat Breaks Above 200-Day Moving Average - Bullish for TRNS
Thursday, August 13, 5:42 PM


SY Crosses Below Key Moving Average Level
Thursday, August 13, 5:41 PM


HNI Crosses Below Key Moving Average Level
Thursday, August 13, 5:39 PM


Bullish Two Hundred Day Moving Average Cross - PLAN
Thursday, August 13, 5:39 PM


CRH.CA Crosses Above Key Moving Average Level
Thursday, August 13, 3:45 PM


CHSCN Makes Bullish Cross Above Critical Moving Average
Thursday, August 13, 11:32 AM


More Technical Analysis News

ABMD DMAABMD MACD
ABIOMED develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily assisting the pumping function of the heart. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP®, which provides more blood flow than the Impella 2.5; Impella RP®, which is a percutaneous catheter-based axial flow pump; and Impella Connect®, which is a cloud-based technology that enables remote viewing of the Automated Impella Controller for physicians and hospital staff from anywhere with internet connectivity.

When researching a stock like ABIOMED, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABMD stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the ABMD 200 day moving average ("ABMD 200 DMA"), while one of the most popular "shorter look-backs" is the ABMD 50 day moving average ("ABMD 50 DMA"). A chart showing both of these popular moving averages is shown on this page for ABIOMED.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABMD:
ABMD SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ABIOMED (ABMD) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

ABT DMA
AGN DMA
ALGN DMA
ALXN DMA
AMGN DMA
BAX DMA
BDX DMA
BIIB DMA
BMY DMA
BSX DMA
More Healthcare companies »

 

ABMD DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.